Disaster Risk Reduction

MEDICALNEWS TODAY                                                            Jan. 6, 2015

Infectious diseases are one of the many health issues that worry the organizers of mass gatherings, such as the Hajj and the World Cup. Geographers' tools of the trade can help event organizers to better plan, monitor and respond timely to such eventualities. The ways in which geographers gather, analyze, and visualize information provide health officials with clearer pictures of the transport routes and environmental factors that may further the spread of viruses to and from the attendees' home countries.

In Chapter 3 of the new book Health, Science and Place: A New Model, geographer and biologist Dr. Amy Blatt explains how geographic information is used for disease surveillance at mass gatherings.
Read complete article

http://www.medicalnewstoday.com/releases/287577.php?tw

Read excerpt from the book,chapter 3.

by Dr. Amy Blatt
http://link.springer.com/chapter/10.1007%2F978-3-319-12003-4_3

REUTERS                                                              Dec. 24, 2014

ACCRA—Medical detective work will be the next big phase in the fight against Ebola when the United Nations deploys hundreds of health workers to identify chains of infection as the virus passes from person to person, top U.N. health workers said.
Health workers bury the body of a suspected Ebola victim at a cemetery in Freetown, Dec. 21, 2014.

The health teams will travel to each district and region of Guinea, Sierra Leone and Liberia, the three countries at the center of the epidemic, to trace who each infected person has potentially contacted.

The effort will run in parallel with measures to minimize the spread of infection, such as treating all Ebola patients in specialized centers and burying all victims safely.

But Phase Two of the plan is to contain the virus by understanding its lines of transmission, said World Health Organization Director-General Margaret Chan.

Read complete story

THE CANADIAN PRESS  by Helen Branswell                                                                     Dec. 19, 2014

TORONTO -- Earlier this week, U.S. President Barack Obama signed into law a little piece of legislation that may significantly change the economics of making drugs or vaccines to protect against Ebola and other viruses in its deadly family.

And it might at some point provide a tidy windfall for Merck, the company now developing an Ebola vaccine designed at Canada's National Microbiology Laboratory in Winnipeg.

A World Health Organization scientist unpacks the Canadian-made Ebola vaccine after receiving them in Geneva on Oct. 22, 2014. Swiss researchers temporarily halted a clinical trial of a Canadian-made Ebola vaccine after seeing an unexpected side-effect in a few people who received the serum. (Mathilde Missioneiro/THE CANADIAN PRESS/HO - WHO)

The bill -- S.2917, also known as "Adding Ebola to the FDA Priority Review Voucher Program Act" -- dangles a sizable carrot meant to entice pharmaceutical companies into developing vaccines and therapies to prevent or cure infection with the virus and other related pathogens in the filovirus family.

NEW YORK TIMES  by Austin Ramzy                                                                 Dec. 7, 2014

LEGAZPI, the Philippines — As Typhoon Hagupit churned across the Philippines on Sunday, residents of the eastern part of the island nation expressed relief that they had joined the hundreds of thousands who had evacuated to safer ground.

Residents waded through floodwaters on Sunday in Borongan City, the Philippines. Typhoon Hagupit is expected to churn over the country until Wednesday. Credit Francis R. Malasig/European Pressphoto Agency

By late Sunday, what had been classified as a super typhoon was far weaker than Haiyan was when it hit, and was continuing to weaken. The storm, which is expected to push its way across the country until Wednesday, was generating strong winds and rain, but the overall effect was not as devastating as worst-case scenarios had anticipated.